MENU

TLX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Telix Pharmaceuticals (TLX) Ownership - Who owns Telix Pharmaceuticals?

Telix develops radiopharmaceuticals to manage cancer... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

3.37B

P/E Ratio

322.10

Total Cash

141.87M

Projected Growth

N/A

Total Debt

467.11M

Revenue

803.79M

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

0.42

Total Debt/Equity

N/A

Revenue/Share

2.48 USD as % of share price

View a ticker or compare two or three

VS

VS

TLX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TLX

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details